Literature DB >> 21296549

Revision total knee arthroplasty: clinical outcome comparison with and without the use of femoral head structural allograft.

Corey J Richards1, Donald S Garbuz, Luke Pugh, Bassam A Masri.   

Abstract

The use of femoral head structural allograft (FHSA) for the management of massive bony defects during revision total knee arthroplasty (TKA) is well documented in the literature. The purpose of this study was to compare the clinical outcomes of patients undergoing revision (TKA) with FHSA to those without. All patients undergoing revision TKA between January 2000 and August 2005 were reviewed. Two cohorts were generated: a study cohort--revision TKA using FHSA (n = 24)--and control cohort--revision TKA without FHSA (n = 48). The 2 study cohorts groups were comparable. All patients completed validated outcome questionnaires. The FHSA cohort was found to have significantly better outcome scores. This study demonstrates improved clinical outcomes for patients undergoing revision TKA using a structural allograft compared with those without.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21296549     DOI: 10.1016/j.arth.2010.12.003

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  Distal femur and proximal tibia replacement with megaprosthesis in revision knee arthroplasty: a limb-saving procedure.

Authors:  Steffen Höll; Annabel Schlomberg; Georg Gosheger; Ralf Dieckmann; Arne Streitbuerger; Dino Schulz; Jendrik Hardes
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-06       Impact factor: 4.342

2.  [Revision implants of the future: trends and new developments].

Authors:  S Winkler; F-X Köck; C Baier; H-R Springorum; A Beifuss; P Lechler; J Grifka; J Schaumburger
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

3.  Comparative assessment of different reconstructive techniques of distal femur in revision total knee arthroplasty.

Authors:  A Completo; F Fonseca; A Ramos; J Simões
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-30       Impact factor: 4.342

4.  No Difference Between Trabecular Metal Cones and Femoral Head Allografts in Revision TKA: Minimum 5-year Followup.

Authors:  Nemandra A Sandiford; Peter Misur; Donald S Garbuz; Nelson V Greidanus; Bassam A Masri
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

5.  Impaction Bone Grafting in Revision Total Knee Arthroplasty-Using Mesh and Cone to Contain the Defect: A Report of 3 Cases.

Authors:  Friedrich Boettner; Ulrich Bechler; Bernhard Springer; Martin Faschingbauer; Anna Jungwirth-Weinberger
Journal:  Arthroplast Today       Date:  2020-08-10

6.  The use of structural allograft in primary and revision knee arthroplasty with bone loss.

Authors:  Raul A Kuchinad; Shawn Garbedian; Benedict A Rogers; David Backstein; Oleg Safir; Allan E Gross
Journal:  Adv Orthop       Date:  2011-09-26

Review 7.  Patient-reported outcome measures following revision knee replacement: a review of PROM instrument utilisation and measurement properties using the COSMIN checklist.

Authors:  Shiraz A Sabah; Elizabeth A Hedge; Simon G F Abram; Abtin Alvand; Andrew J Price; Sally Hopewell
Journal:  BMJ Open       Date:  2021-10-21       Impact factor: 2.692

8.  Application of structural allogenous bone graft in two-stage exchange arthroplasty for knee periprosthetic joint infection: a case control study.

Authors:  Chieh An Chuang; Sheng-Hsun Lee; Chih-Hsiang Chang; Chih-Chien Hu; Hsin-Nung Shih; Steve W N Ueng; Yuhan Chang
Journal:  BMC Musculoskelet Disord       Date:  2022-04-05       Impact factor: 2.362

9.  Lyophilized Human Bone Allograft as an Antibiotic Carrier: An In Vitro and In Vivo Study.

Authors:  Débora C Coraça-Huber; Stephan J M Steixner; Stevo Najman; Sanja Stojanovic; Ronja Finze; Denis Rimashevskiy; Dina Saginova; Mike Barbeck; Reinhard Schnettler
Journal:  Antibiotics (Basel)       Date:  2022-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.